Standard whole prostate gland radiotherapy with and without lesion boost in prostate cancer: Toxicity in the FLAME randomized controlled trial
To compare toxicity rates in patients with localized prostate cancer treated with standard fractionated external beam radiotherapy (EBRT) with or without an additional integrated boost to the macroscopically visible tumour.
Source: Radiotherapy and Oncology - Category: Radiology Authors: Evelyn M. Monninkhof, Juliette W.L. van Loon, Marco van Vulpen, Linda G.W. Kerkmeijer, Floris J. Pos, Karin Haustermans, Laura van den Bergh, Sofie Isebaert, Gill M. McColl, Robert Jan Smeenk, Juus Noteboom, Iris Walraven, Petra H.M. Peeters, Uulke A. van Tags: Original article Source Type: research
More News: Cancer | Cancer & Oncology | External Beam Therapy | Prostate Cancer | Radiology | Toxicology